nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Levomethadyl Acetate—CHRNB4—lung cancer	0.00558	0.264	CrCbGaD
Doxylamine—Levomethadyl Acetate—CHRNA3—lung cancer	0.00387	0.183	CrCbGaD
Doxylamine—Toremifene—CYP1A1—lung cancer	0.00169	0.0801	CrCbGaD
Doxylamine—Carbinoxamine—CYP2E1—lung cancer	0.00122	0.0577	CrCbGaD
Doxylamine—Brompheniramine—CYP2E1—lung cancer	0.00106	0.05	CrCbGaD
Doxylamine—Tamoxifen—CYP2A6—lung cancer	0.000966	0.0456	CrCbGaD
Doxylamine—Convulsion—Etoposide—lung cancer	0.000965	0.000986	CcSEcCtD
Doxylamine—Insomnia—Gemcitabine—lung cancer	0.000963	0.000983	CcSEcCtD
Doxylamine—Immune system disorder—Docetaxel—lung cancer	0.00096	0.000981	CcSEcCtD
Doxylamine—Diplopia—Doxorubicin—lung cancer	0.000959	0.00098	CcSEcCtD
Doxylamine—Hyperhidrosis—Cisplatin—lung cancer	0.000959	0.00098	CcSEcCtD
Doxylamine—Mediastinal disorder—Docetaxel—lung cancer	0.000958	0.000979	CcSEcCtD
Doxylamine—Asthenia—Vinorelbine—lung cancer	0.000951	0.000971	CcSEcCtD
Doxylamine—Decreased appetite—Irinotecan—lung cancer	0.00095	0.00097	CcSEcCtD
Doxylamine—Dyspnoea—Gemcitabine—lung cancer	0.000949	0.000969	CcSEcCtD
Doxylamine—Nausea—Vinblastine—lung cancer	0.000947	0.000967	CcSEcCtD
Doxylamine—Somnolence—Gemcitabine—lung cancer	0.000946	0.000967	CcSEcCtD
Doxylamine—Convulsion—Paclitaxel—lung cancer	0.000946	0.000966	CcSEcCtD
Doxylamine—Anorexia—Cisplatin—lung cancer	0.000946	0.000966	CcSEcCtD
Doxylamine—Affect lability—Doxorubicin—lung cancer	0.000944	0.000964	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000943	0.000964	CcSEcCtD
Doxylamine—Fatigue—Irinotecan—lung cancer	0.000942	0.000962	CcSEcCtD
Doxylamine—Pancreatitis—Methotrexate—lung cancer	0.000939	0.000959	CcSEcCtD
Doxylamine—Pruritus—Vinorelbine—lung cancer	0.000937	0.000958	CcSEcCtD
Doxylamine—Discomfort—Etoposide—lung cancer	0.000937	0.000957	CcSEcCtD
Doxylamine—Constipation—Irinotecan—lung cancer	0.000934	0.000955	CcSEcCtD
Doxylamine—Hypotension—Cisplatin—lung cancer	0.000927	0.000947	CcSEcCtD
Doxylamine—Anxiety—Paclitaxel—lung cancer	0.000926	0.000946	CcSEcCtD
Doxylamine—Erythema—Docetaxel—lung cancer	0.000925	0.000945	CcSEcCtD
Doxylamine—Decreased appetite—Gemcitabine—lung cancer	0.000925	0.000945	CcSEcCtD
Doxylamine—Nausea—Topotecan—lung cancer	0.00092	0.00094	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000919	0.000939	CcSEcCtD
Doxylamine—Discomfort—Paclitaxel—lung cancer	0.000918	0.000938	CcSEcCtD
Doxylamine—Abdominal discomfort—Methotrexate—lung cancer	0.000918	0.000938	CcSEcCtD
Doxylamine—Fatigue—Gemcitabine—lung cancer	0.000918	0.000937	CcSEcCtD
Doxylamine—Confusional state—Etoposide—lung cancer	0.000916	0.000936	CcSEcCtD
Doxylamine—Constipation—Gemcitabine—lung cancer	0.00091	0.00093	CcSEcCtD
Doxylamine—Nausea—Erlotinib—lung cancer	0.00091	0.00093	CcSEcCtD
Doxylamine—Pancytopenia—Methotrexate—lung cancer	0.000909	0.000929	CcSEcCtD
Doxylamine—Dry mouth—Paclitaxel—lung cancer	0.000909	0.000929	CcSEcCtD
Doxylamine—Anaphylactic shock—Etoposide—lung cancer	0.000909	0.000928	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—lung cancer	0.000909	0.000928	CcSEcCtD
Doxylamine—Diarrhoea—Vinorelbine—lung cancer	0.000906	0.000926	CcSEcCtD
Doxylamine—Feeling abnormal—Irinotecan—lung cancer	0.0009	0.00092	CcSEcCtD
Doxylamine—Toremifene—ABCB1—lung cancer	0.0009	0.0425	CrCbGaD
Doxylamine—Confusional state—Paclitaxel—lung cancer	0.000899	0.000918	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—lung cancer	0.000892	0.000911	CcSEcCtD
Doxylamine—Anaphylactic shock—Paclitaxel—lung cancer	0.000891	0.00091	CcSEcCtD
Doxylamine—Thrombocytopenia—Etoposide—lung cancer	0.00089	0.000909	CcSEcCtD
Doxylamine—Muscle spasms—Docetaxel—lung cancer	0.00089	0.000909	CcSEcCtD
Doxylamine—Tachycardia—Etoposide—lung cancer	0.000887	0.000906	CcSEcCtD
Doxylamine—Dyspnoea—Cisplatin—lung cancer	0.000884	0.000904	CcSEcCtD
Doxylamine—Hyperhidrosis—Etoposide—lung cancer	0.000879	0.000898	CcSEcCtD
Doxylamine—Feeling abnormal—Gemcitabine—lung cancer	0.000877	0.000896	CcSEcCtD
Doxylamine—Dizziness—Vinorelbine—lung cancer	0.000876	0.000895	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000876	0.000895	CcSEcCtD
Doxylamine—Nervous system disorder—Paclitaxel—lung cancer	0.000874	0.000893	CcSEcCtD
Doxylamine—Thrombocytopenia—Paclitaxel—lung cancer	0.000872	0.000891	CcSEcCtD
Doxylamine—Tachycardia—Paclitaxel—lung cancer	0.00087	0.000889	CcSEcCtD
Doxylamine—Breast disorder—Doxorubicin—lung cancer	0.000867	0.000885	CcSEcCtD
Doxylamine—Anorexia—Etoposide—lung cancer	0.000866	0.000885	CcSEcCtD
Doxylamine—Tamoxifen—ABCG2—lung cancer	0.000864	0.0408	CrCbGaD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000864	0.000882	CcSEcCtD
Doxylamine—Decreased appetite—Cisplatin—lung cancer	0.000862	0.000881	CcSEcCtD
Doxylamine—Hyperhidrosis—Paclitaxel—lung cancer	0.000861	0.00088	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—lung cancer	0.000858	0.000876	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000856	0.000875	CcSEcCtD
Doxylamine—Drowsiness—Methotrexate—lung cancer	0.000854	0.000872	CcSEcCtD
Doxylamine—Depression—Methotrexate—lung cancer	0.000851	0.00087	CcSEcCtD
Doxylamine—Anorexia—Paclitaxel—lung cancer	0.000849	0.000868	CcSEcCtD
Doxylamine—Hypotension—Etoposide—lung cancer	0.000849	0.000868	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000846	0.000865	CcSEcCtD
Doxylamine—Vomiting—Vinorelbine—lung cancer	0.000842	0.000861	CcSEcCtD
Doxylamine—Rash—Vinorelbine—lung cancer	0.000835	0.000853	CcSEcCtD
Doxylamine—Dermatitis—Vinorelbine—lung cancer	0.000835	0.000853	CcSEcCtD
Doxylamine—Hypotension—Paclitaxel—lung cancer	0.000833	0.000851	CcSEcCtD
Doxylamine—Leukopenia—Docetaxel—lung cancer	0.000828	0.000846	CcSEcCtD
Doxylamine—Sweating—Methotrexate—lung cancer	0.000818	0.000836	CcSEcCtD
Doxylamine—Palpitations—Docetaxel—lung cancer	0.000818	0.000836	CcSEcCtD
Doxylamine—Feeling abnormal—Cisplatin—lung cancer	0.000818	0.000835	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—lung cancer	0.000813	0.00083	CcSEcCtD
Doxylamine—Dyspnoea—Etoposide—lung cancer	0.00081	0.000828	CcSEcCtD
Doxylamine—Somnolence—Etoposide—lung cancer	0.000808	0.000825	CcSEcCtD
Doxylamine—Insomnia—Paclitaxel—lung cancer	0.000806	0.000823	CcSEcCtD
Doxylamine—Hypersensitivity—Irinotecan—lung cancer	0.000805	0.000822	CcSEcCtD
Doxylamine—Convulsion—Docetaxel—lung cancer	0.000802	0.000819	CcSEcCtD
Doxylamine—Agranulocytosis—Methotrexate—lung cancer	0.000797	0.000814	CcSEcCtD
Doxylamine—Dyspnoea—Paclitaxel—lung cancer	0.000794	0.000812	CcSEcCtD
Doxylamine—Somnolence—Paclitaxel—lung cancer	0.000792	0.000809	CcSEcCtD
Doxylamine—Decreased appetite—Etoposide—lung cancer	0.00079	0.000807	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—lung cancer	0.000787	0.000804	CcSEcCtD
Doxylamine—Nausea—Vinorelbine—lung cancer	0.000787	0.000804	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Etoposide—lung cancer	0.000785	0.000802	CcSEcCtD
Doxylamine—Asthenia—Irinotecan—lung cancer	0.000784	0.000801	CcSEcCtD
Doxylamine—Fatigue—Etoposide—lung cancer	0.000784	0.000801	CcSEcCtD
Doxylamine—Constipation—Etoposide—lung cancer	0.000777	0.000794	CcSEcCtD
Doxylamine—Decreased appetite—Paclitaxel—lung cancer	0.000775	0.000791	CcSEcCtD
Doxylamine—Dry mouth—Docetaxel—lung cancer	0.000771	0.000787	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000769	0.000786	CcSEcCtD
Doxylamine—Fatigue—Paclitaxel—lung cancer	0.000768	0.000785	CcSEcCtD
Doxylamine—Hepatitis—Methotrexate—lung cancer	0.000766	0.000783	CcSEcCtD
Doxylamine—Asthenia—Gemcitabine—lung cancer	0.000764	0.00078	CcSEcCtD
Doxylamine—Constipation—Paclitaxel—lung cancer	0.000762	0.000779	CcSEcCtD
Doxylamine—Confusional state—Docetaxel—lung cancer	0.000762	0.000778	CcSEcCtD
Doxylamine—Urinary tract disorder—Methotrexate—lung cancer	0.000757	0.000773	CcSEcCtD
Doxylamine—Anaphylactic shock—Docetaxel—lung cancer	0.000755	0.000772	CcSEcCtD
Doxylamine—Pruritus—Gemcitabine—lung cancer	0.000753	0.000769	CcSEcCtD
Doxylamine—Urethral disorder—Methotrexate—lung cancer	0.000751	0.000767	CcSEcCtD
Doxylamine—Feeling abnormal—Etoposide—lung cancer	0.000749	0.000765	CcSEcCtD
Doxylamine—Diarrhoea—Irinotecan—lung cancer	0.000748	0.000764	CcSEcCtD
Doxylamine—Nervous system disorder—Docetaxel—lung cancer	0.000741	0.000757	CcSEcCtD
Doxylamine—Thrombocytopenia—Docetaxel—lung cancer	0.00074	0.000756	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—lung cancer	0.000739	0.000755	CcSEcCtD
Doxylamine—Tachycardia—Docetaxel—lung cancer	0.000737	0.000753	CcSEcCtD
Doxylamine—Feeling abnormal—Paclitaxel—lung cancer	0.000734	0.00075	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000733	0.000749	CcSEcCtD
Doxylamine—Hypersensitivity—Cisplatin—lung cancer	0.000731	0.000747	CcSEcCtD
Doxylamine—Diarrhoea—Gemcitabine—lung cancer	0.000728	0.000744	CcSEcCtD
Doxylamine—Erythema multiforme—Methotrexate—lung cancer	0.000724	0.00074	CcSEcCtD
Doxylamine—Dizziness—Irinotecan—lung cancer	0.000723	0.000738	CcSEcCtD
Doxylamine—Urticaria—Etoposide—lung cancer	0.000722	0.000738	CcSEcCtD
Doxylamine—Anorexia—Docetaxel—lung cancer	0.00072	0.000736	CcSEcCtD
Doxylamine—Eye disorder—Methotrexate—lung cancer	0.000716	0.000732	CcSEcCtD
Doxylamine—Asthenia—Cisplatin—lung cancer	0.000712	0.000727	CcSEcCtD
Doxylamine—Cardiac disorder—Methotrexate—lung cancer	0.000711	0.000727	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—lung cancer	0.000709	0.000724	CcSEcCtD
Doxylamine—Urticaria—Paclitaxel—lung cancer	0.000708	0.000723	CcSEcCtD
Doxylamine—Hypotension—Docetaxel—lung cancer	0.000706	0.000721	CcSEcCtD
Doxylamine—Vomiting—Irinotecan—lung cancer	0.000695	0.00071	CcSEcCtD
Doxylamine—Immune system disorder—Methotrexate—lung cancer	0.000692	0.000707	CcSEcCtD
Doxylamine—Mediastinal disorder—Methotrexate—lung cancer	0.000691	0.000706	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—lung cancer	0.00069	0.000705	CcSEcCtD
Doxylamine—Rash—Irinotecan—lung cancer	0.000689	0.000704	CcSEcCtD
Doxylamine—Dermatitis—Irinotecan—lung cancer	0.000688	0.000703	CcSEcCtD
Doxylamine—Tamoxifen—CYP2E1—lung cancer	0.000686	0.0324	CrCbGaD
Doxylamine—Insomnia—Docetaxel—lung cancer	0.000683	0.000698	CcSEcCtD
Doxylamine—Diarrhoea—Cisplatin—lung cancer	0.000679	0.000693	CcSEcCtD
Doxylamine—Vomiting—Gemcitabine—lung cancer	0.000677	0.000691	CcSEcCtD
Doxylamine—Tamoxifen—CYP1A1—lung cancer	0.000676	0.032	CrCbGaD
Doxylamine—Bradycardia—Doxorubicin—lung cancer	0.000675	0.00069	CcSEcCtD
Doxylamine—Dyspnoea—Docetaxel—lung cancer	0.000673	0.000688	CcSEcCtD
Doxylamine—Somnolence—Docetaxel—lung cancer	0.000671	0.000686	CcSEcCtD
Doxylamine—Rash—Gemcitabine—lung cancer	0.000671	0.000686	CcSEcCtD
Doxylamine—Dermatitis—Gemcitabine—lung cancer	0.00067	0.000685	CcSEcCtD
Doxylamine—Hypersensitivity—Etoposide—lung cancer	0.00067	0.000684	CcSEcCtD
Doxylamine—Erythema—Methotrexate—lung cancer	0.000667	0.000681	CcSEcCtD
Doxylamine—Orphenadrine—CYP2E1—lung cancer	0.000666	0.0315	CrCbGaD
Doxylamine—Hepatitis—Doxorubicin—lung cancer	0.000664	0.000678	CcSEcCtD
Doxylamine—Decreased appetite—Docetaxel—lung cancer	0.000657	0.000671	CcSEcCtD
Doxylamine—Hypersensitivity—Paclitaxel—lung cancer	0.000657	0.000671	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—lung cancer	0.000655	0.000669	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000652	0.000666	CcSEcCtD
Doxylamine—Asthenia—Etoposide—lung cancer	0.000652	0.000666	CcSEcCtD
Doxylamine—Fatigue—Docetaxel—lung cancer	0.000651	0.000665	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—lung cancer	0.00065	0.000664	CcSEcCtD
Doxylamine—Nausea—Irinotecan—lung cancer	0.000649	0.000663	CcSEcCtD
Doxylamine—Constipation—Docetaxel—lung cancer	0.000646	0.00066	CcSEcCtD
Doxylamine—Pruritus—Etoposide—lung cancer	0.000643	0.000657	CcSEcCtD
Doxylamine—Asthenia—Paclitaxel—lung cancer	0.000639	0.000653	CcSEcCtD
Doxylamine—Nausea—Gemcitabine—lung cancer	0.000632	0.000646	CcSEcCtD
Doxylamine—Vomiting—Cisplatin—lung cancer	0.000631	0.000644	CcSEcCtD
Doxylamine—Pruritus—Paclitaxel—lung cancer	0.00063	0.000644	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—lung cancer	0.000627	0.000641	CcSEcCtD
Doxylamine—Rash—Cisplatin—lung cancer	0.000626	0.000639	CcSEcCtD
Doxylamine—Dermatitis—Cisplatin—lung cancer	0.000625	0.000638	CcSEcCtD
Doxylamine—Feeling abnormal—Docetaxel—lung cancer	0.000622	0.000636	CcSEcCtD
Doxylamine—Diarrhoea—Etoposide—lung cancer	0.000622	0.000635	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—lung cancer	0.00062	0.000633	CcSEcCtD
Doxylamine—Ill-defined disorder—Methotrexate—lung cancer	0.000619	0.000632	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—lung cancer	0.000616	0.000629	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—lung cancer	0.000616	0.000629	CcSEcCtD
Doxylamine—Diarrhoea—Paclitaxel—lung cancer	0.00061	0.000623	CcSEcCtD
Doxylamine—Malaise—Methotrexate—lung cancer	0.000602	0.000615	CcSEcCtD
Doxylamine—Dizziness—Etoposide—lung cancer	0.000601	0.000614	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—lung cancer	0.000599	0.000612	CcSEcCtD
Doxylamine—Vertigo—Methotrexate—lung cancer	0.000599	0.000612	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—lung cancer	0.000598	0.000611	CcSEcCtD
Doxylamine—Leukopenia—Methotrexate—lung cancer	0.000597	0.00061	CcSEcCtD
Doxylamine—Dizziness—Paclitaxel—lung cancer	0.000589	0.000602	CcSEcCtD
Doxylamine—Nausea—Cisplatin—lung cancer	0.000589	0.000602	CcSEcCtD
Doxylamine—Convulsion—Methotrexate—lung cancer	0.000578	0.00059	CcSEcCtD
Doxylamine—Vomiting—Etoposide—lung cancer	0.000578	0.00059	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—lung cancer	0.000578	0.00059	CcSEcCtD
Doxylamine—Rash—Etoposide—lung cancer	0.000573	0.000585	CcSEcCtD
Doxylamine—Dermatitis—Etoposide—lung cancer	0.000573	0.000585	CcSEcCtD
Doxylamine—Vomiting—Paclitaxel—lung cancer	0.000567	0.000579	CcSEcCtD
Doxylamine—Rash—Paclitaxel—lung cancer	0.000562	0.000574	CcSEcCtD
Doxylamine—Dermatitis—Paclitaxel—lung cancer	0.000561	0.000573	CcSEcCtD
Doxylamine—Discomfort—Methotrexate—lung cancer	0.000561	0.000573	CcSEcCtD
Doxylamine—Hypersensitivity—Docetaxel—lung cancer	0.000556	0.000569	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—lung cancer	0.000555	0.000567	CcSEcCtD
Doxylamine—Confusional state—Methotrexate—lung cancer	0.000549	0.000561	CcSEcCtD
Doxylamine—Anaphylactic shock—Methotrexate—lung cancer	0.000544	0.000556	CcSEcCtD
Doxylamine—Asthenia—Docetaxel—lung cancer	0.000542	0.000554	CcSEcCtD
Doxylamine—Nausea—Etoposide—lung cancer	0.00054	0.000552	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—lung cancer	0.000536	0.000547	CcSEcCtD
Doxylamine—Pruritus—Docetaxel—lung cancer	0.000534	0.000546	CcSEcCtD
Doxylamine—Nervous system disorder—Methotrexate—lung cancer	0.000534	0.000545	CcSEcCtD
Doxylamine—Thrombocytopenia—Methotrexate—lung cancer	0.000533	0.000545	CcSEcCtD
Doxylamine—Imipramine—CYP2E1—lung cancer	0.000532	0.0251	CrCbGaD
Doxylamine—Agitation—Doxorubicin—lung cancer	0.000531	0.000542	CcSEcCtD
Doxylamine—Nausea—Paclitaxel—lung cancer	0.000529	0.000541	CcSEcCtD
Doxylamine—Amitriptyline—CYP2E1—lung cancer	0.000529	0.025	CrCbGaD
Doxylamine—Hyperhidrosis—Methotrexate—lung cancer	0.000526	0.000538	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—lung cancer	0.000521	0.000532	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—lung cancer	0.000519	0.00053	CcSEcCtD
Doxylamine—Anorexia—Methotrexate—lung cancer	0.000519	0.00053	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—lung cancer	0.000517	0.000528	CcSEcCtD
Doxylamine—Diarrhoea—Docetaxel—lung cancer	0.000517	0.000528	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—lung cancer	0.00051	0.000521	CcSEcCtD
Doxylamine—Hypotension—Methotrexate—lung cancer	0.000509	0.00052	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—lung cancer	0.0005	0.000511	CcSEcCtD
Doxylamine—Dizziness—Docetaxel—lung cancer	0.000499	0.00051	CcSEcCtD
Doxylamine—Insomnia—Methotrexate—lung cancer	0.000492	0.000503	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—lung cancer	0.00049	0.000501	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—lung cancer	0.000486	0.000496	CcSEcCtD
Doxylamine—Dyspnoea—Methotrexate—lung cancer	0.000485	0.000496	CcSEcCtD
Doxylamine—Somnolence—Methotrexate—lung cancer	0.000484	0.000494	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—lung cancer	0.000481	0.000491	CcSEcCtD
Doxylamine—Vomiting—Docetaxel—lung cancer	0.00048	0.000491	CcSEcCtD
Doxylamine—Rash—Docetaxel—lung cancer	0.000476	0.000487	CcSEcCtD
Doxylamine—Dermatitis—Docetaxel—lung cancer	0.000476	0.000486	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—lung cancer	0.000475	0.000486	CcSEcCtD
Doxylamine—Decreased appetite—Methotrexate—lung cancer	0.000473	0.000483	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—lung cancer	0.000471	0.000482	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Methotrexate—lung cancer	0.00047	0.00048	CcSEcCtD
Doxylamine—Fatigue—Methotrexate—lung cancer	0.000469	0.000479	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—lung cancer	0.000462	0.000472	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—lung cancer	0.000462	0.000472	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—lung cancer	0.00046	0.00047	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—lung cancer	0.000456	0.000466	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—lung cancer	0.000449	0.000459	CcSEcCtD
Doxylamine—Nausea—Docetaxel—lung cancer	0.000449	0.000458	CcSEcCtD
Doxylamine—Feeling abnormal—Methotrexate—lung cancer	0.000449	0.000458	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—lung cancer	0.00044	0.00045	CcSEcCtD
Doxylamine—Urticaria—Methotrexate—lung cancer	0.000432	0.000442	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—lung cancer	0.000426	0.000436	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—lung cancer	0.00042	0.000429	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—lung cancer	0.000419	0.000428	CcSEcCtD
Doxylamine—Decreased appetite—Doxorubicin—lung cancer	0.00041	0.000419	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000407	0.000416	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—lung cancer	0.000406	0.000415	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—lung cancer	0.000403	0.000412	CcSEcCtD
Doxylamine—Hypersensitivity—Methotrexate—lung cancer	0.000401	0.00041	CcSEcCtD
Doxylamine—Asthenia—Methotrexate—lung cancer	0.000391	0.000399	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—lung cancer	0.000388	0.000397	CcSEcCtD
Doxylamine—Pruritus—Methotrexate—lung cancer	0.000385	0.000393	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—lung cancer	0.000374	0.000383	CcSEcCtD
Doxylamine—Diarrhoea—Methotrexate—lung cancer	0.000372	0.000381	CcSEcCtD
Doxylamine—Dizziness—Methotrexate—lung cancer	0.00036	0.000368	CcSEcCtD
Doxylamine—Tamoxifen—ABCB1—lung cancer	0.000359	0.017	CrCbGaD
Doxylamine—Doxepin—ABCB1—lung cancer	0.000358	0.0169	CrCbGaD
Doxylamine—Methadone—ABCB1—lung cancer	0.000356	0.0168	CrCbGaD
Doxylamine—Hypersensitivity—Doxorubicin—lung cancer	0.000347	0.000355	CcSEcCtD
Doxylamine—Vomiting—Methotrexate—lung cancer	0.000346	0.000354	CcSEcCtD
Doxylamine—Rash—Methotrexate—lung cancer	0.000343	0.000351	CcSEcCtD
Doxylamine—Dermatitis—Methotrexate—lung cancer	0.000343	0.00035	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—lung cancer	0.000338	0.000346	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—lung cancer	0.000334	0.000341	CcSEcCtD
Doxylamine—Nausea—Methotrexate—lung cancer	0.000323	0.00033	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—lung cancer	0.000323	0.000329	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—lung cancer	0.000312	0.000318	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—lung cancer	0.0003	0.000306	CcSEcCtD
Doxylamine—Rash—Doxorubicin—lung cancer	0.000297	0.000304	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—lung cancer	0.000297	0.000303	CcSEcCtD
Doxylamine—Amitriptyline—ALB—lung cancer	0.00029	0.0137	CrCbGaD
Doxylamine—Nausea—Doxorubicin—lung cancer	0.00028	0.000286	CcSEcCtD
Doxylamine—Imipramine—ABCB1—lung cancer	0.000279	0.0132	CrCbGaD
Doxylamine—Amitriptyline—ABCB1—lung cancer	0.000277	0.0131	CrCbGaD
